154 related articles for article (PubMed ID: 9090476)
1. Taxanes in ovarian cancer treatment.
Seetalarom K; Kudelka AP; Verschraegen CF; Kavanagh JJ
Curr Opin Obstet Gynecol; 1997 Feb; 9(1):14-20. PubMed ID: 9090476
[TBL] [Abstract][Full Text] [Related]
2. Docetaxel in the treatment of ovarian cancer.
Kavanagh JJ
Oncology (Williston Park); 2002 Jun; 16(6 Suppl 6):73-81. PubMed ID: 12108900
[TBL] [Abstract][Full Text] [Related]
3. Clinical overview of the taxanes.
Goldspiel BR
Pharmacotherapy; 1997; 17(5 Pt 2):110S-125S. PubMed ID: 9322878
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of docetaxel in patients with epithelial ovarian carcinoma refractory to platinum.
Kavanagh JJ; Kudelka AP; de Leon CG; Tresukosol D; Hord M; Finnegan MB; Kim EE; Varma D; Forman A; Cohen P; Edwards CL; Freedman RS; Verschraegen CF
Clin Cancer Res; 1996 May; 2(5):837-42. PubMed ID: 9816238
[TBL] [Abstract][Full Text] [Related]
5. Intraperitoneal chemotherapy with taxanes for ovarian cancer with peritoneal dissemination.
de Bree E; Rosing H; Michalakis J; Romanos J; Relakis K; Theodoropoulos PA; Beijnen JH; Georgoulias V; Tsiftsis DD
Eur J Surg Oncol; 2006 Aug; 32(6):666-70. PubMed ID: 16618534
[TBL] [Abstract][Full Text] [Related]
6. Risks and benefits of taxanes in breast and ovarian cancer.
Michaud LB; Valero V; Hortobagyi G
Drug Saf; 2000 Nov; 23(5):401-28. PubMed ID: 11085347
[TBL] [Abstract][Full Text] [Related]
7. Medical therapy of advanced malignant epithelial tumours of the ovary.
Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
[TBL] [Abstract][Full Text] [Related]
8. Paclitaxel and docetaxel in breast and ovarian cancer.
Drug Ther Bull; 1997 Jun; 35(6):43-6. PubMed ID: 9282422
[TBL] [Abstract][Full Text] [Related]
9. Options for primary chemotherapy of epithelial ovarian cancer: taxanes.
Trimble EL; Arbuck SG; McGuire WP
Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S114-21. PubMed ID: 7835794
[TBL] [Abstract][Full Text] [Related]
10. Taxoids: a new class of cytotoxic agents.
Marty M; Extra JM; Giacchetti S; Cuvier C; Espie M
Nouv Rev Fr Hematol (1978); 1994; 36 Suppl 1():S25-8. PubMed ID: 7909941
[TBL] [Abstract][Full Text] [Related]
11. New options for the treatment of advanced ovarian cancer.
Dunton CJ
Semin Oncol; 1997 Feb; 24(1 Suppl 5):S5-2-S5-11. PubMed ID: 9122739
[TBL] [Abstract][Full Text] [Related]
12. Overview of docetaxel (Taxotere) in the treatment of non-small cell lung cancer.
Fossella FV
Semin Oncol; 1999 Jun; 26(3 Suppl 11):4-8. PubMed ID: 10458203
[TBL] [Abstract][Full Text] [Related]
13. Emerging role of docetaxel (Taxotere) in advanced non-small cell lung cancer.
Gandara DR; Edelman MJ; Lau D
Semin Oncol; 1999 Jun; 26(3 Suppl 10):3-7. PubMed ID: 10437743
[TBL] [Abstract][Full Text] [Related]
14. Paclitaxel in patients with platinum-resistant ovarian cancer: a selected review of literature and clinical experience.
Kudelka AP; Tresukosol D; Gonzalez de Leon C; Termrungruanglert W; Edwards CL; Freedman RS; Tornos C; Kavanagh JJ
J Med Assoc Thai; 1996 Apr; 79(4):240-5. PubMed ID: 8708510
[TBL] [Abstract][Full Text] [Related]
15. Taxol as second-line treatment in patients with advanced ovarian cancer after platinum-based first-line chemotherapy.
Mayerhofer K; Kucera E; Zeisler H; Speiser P; Reinthaller A; Sevelda P
Gynecol Oncol; 1997 Jan; 64(1):109-13. PubMed ID: 8995557
[TBL] [Abstract][Full Text] [Related]
16. Docetaxel in anthracycline-resistant metastatic breast cancer.
Hui YF; Ignoffo RJ
Cancer Pract; 1997; 5(2):124-7. PubMed ID: 9110651
[TBL] [Abstract][Full Text] [Related]
17. Is there a place for "dose-dense" weekly schedules of the taxoids?
Löffler TM
Semin Oncol; 1998 Oct; 25(5 Suppl 12):32-4. PubMed ID: 9865710
[TBL] [Abstract][Full Text] [Related]
18. Taxanes in the treatment of breast cancer: a prodigy comes of age.
Miller KD; Sledge GW
Cancer Invest; 1999; 17(2):121-36. PubMed ID: 10071597
[TBL] [Abstract][Full Text] [Related]
19. Summary of phase II data of docetaxel (Taxotere), an active agent in the first- and second-line treatment of advanced non-small cell lung cancer.
Fossella FV; Lee JS; Berille J; Hong WK
Semin Oncol; 1995 Apr; 22(2 Suppl 4):22-9. PubMed ID: 7740327
[TBL] [Abstract][Full Text] [Related]
20. [Taxanes in the treatment of breast and ovarian cancers: current indications and results].
Espié M; Cuvier C; Gorins A; Marty M
Contracept Fertil Sex; 1998 Nov; 26(11):805-11. PubMed ID: 9864888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]